Impact of Sex in the Prevalence and Progression of Glioblastomas: the Role of Gonadal Steroid Hormones

Overview

Journal Biol Sex Differ

Publisher Biomed Central

Specialties Biology
Physiology

Date 2021 Mar 23

PMID 33752729

Citations 15

Authors

Claudia Bello-Alvarez

Ignacio Camacho-Arroyo

Affiliations

Soon will be listed here.

Abstract

Background: As in other types of cancers, sex is an essential factor in the origin and progression of glioblastomas. Research in the field of endocrinology and cancer suggests that gonadal steroid hormones play an important role in the progression and prevalence of glioblastomas. In the present review, we aim to discuss the actions and mechanism triggered by gonadal steroid hormones in glioblastomas.

Main Body: Glioblastoma is the most common malignant primary brain tumor. According to the epidemiological data, glioblastomas are more frequent in men than in women in a 1.6/1 proportion both in children and adults. This evidence, and the knowledge about sex influence over the prevalence of countless diseases, suggest that male gonadal steroid hormones, such as testosterone, promote glioblastomas growth. In contrast, a protective role of female gonadal steroid hormones (estradiol and progesterone) against glioblastomas has been questioned. Several pieces of evidence demonstrate a variety of effects induced by female and male gonadal steroid hormones in glioblastomas. Several studies indicate that pregnancy, a physiological state with the highest progesterone and estradiol levels, accelerates the progression of low-grade astrocytomas to glioblastomas and increases the symptoms associated with these tumors. In vitro studies have demonstrated that progesterone has a dual role in glioblastoma cells: physiological concentrations promote cell proliferation, migration, and invasion while very high doses (out physiological range) reduce cell proliferation and increases cell death.

Conclusion: Gonadal steroid hormones can stimulate the progression of glioblastomas through the increase in proliferation, migration, and invasion. However, the effects mentioned above depend on the concentrations of these hormones and the receptor involved in hormone actions. Estradiol and progesterone can exert promoter or protective effects while the role of testosterone has been always associated to glioblastomas progression.

Citing Articles

Suppression of FOXO1 activity by SIRT1-mediated deacetylation weakening the intratumoral androgen autocrine function in glioblastoma.

Cheng Y, Xiao Z, Cai W, Zhou T, Yang Z Cancer Gene Ther. 2025; .

PMID: 40075208 DOI: 10.1038/s41417-025-00880-1.

Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.

Rossi J, Zedde M, Napoli M, Pascarella R, Pisanello A, Biagini G Life (Basel). 2025; 14(12.

PMID: 39768232 PMC: 11677825. DOI: 10.3390/life14121523.

Impact of Age and Gender on Survival of Glioblastoma Multiforme Patients: A Multicenter Retrospective Study.

Reihanian Z, Abbaspour E, Zaresharifi N, Karimzadhagh S, Mahmoudalinejad M, Sourati A Cancer Rep (Hoboken). 2024; 7(11):e70050.

PMID: 39506810 PMC: 11541054. DOI: 10.1002/cnr2.70050.

Genetic Prognostic Factors in Adult Diffuse Gliomas: A 10-Year Experience at a Single Institution.

Behrooz A, Darzi Ramandi H, Latifi-Navid H, Peymani P, Tarharoudi R, Momeni N Cancers (Basel). 2024; 16(11).

PMID: 38893240 PMC: 11172038. DOI: 10.3390/cancers16112121.

Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders.

Balan I, Boero G, Chery S, McFarland M, Lopez A, Morrow A Life (Basel). 2024; 14(5).

PMID: 38792602 PMC: 11122352. DOI: 10.3390/life14050582.

References

Chowen J, Torres-Aleman I, Garcia-Segura L . Trophic effects of estradiol on fetal rat hypothalamic neurons. Neuroendocrinology. 1992; 56(6):895-901. DOI: 10.1159/000126321. View

Gutierrez-Rodriguez A, Hansberg-Pastor V, Camacho-Arroyo I . Proliferative and Invasive Effects of Progesterone-Induced Blocking Factor in Human Glioblastoma Cells. Biomed Res Int. 2017; 2017:1295087. PMC: 5266854. DOI: 10.1155/2017/1295087. View

Tang W, Liu R, Yan Y, Pan X, Wang M, Han X . Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer. Oncotarget. 2017; 8(25):40765-40777. PMC: 5522298. DOI: 10.18632/oncotarget.16582. View

Jo E, Kumaki S, Wei D, Tsuchiya S, Kanegane H, Song C . X-linked severe combined immunodeficiency syndrome: the first Korean case with gamma c chain gene mutation and subsequent genetic counseling. J Korean Med Sci. 2004; 19(1):123-6. PMC: 2822247. DOI: 10.3346/jkms.2004.19.1.123. View

Check J, Wilson C, Cohen R, Sarumi M . Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV. Anticancer Res. 2014; 34(5):2385-8. View

Cabrera-Munoz E, Gonzalez-Arenas A, Saqui-Salces M, Camacho J, Larrea F, Garcia-Becerra R . Regulation of progesterone receptor isoforms content in human astrocytoma cell lines. J Steroid Biochem Mol Biol. 2008; 113(1-2):80-4. DOI: 10.1016/j.jsbmb.2008.11.009. View

Lan Y, Wang X, Lou J, Ma B, Xing J, Zou S . Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies. J Neurooncol. 2017; 137(2):357-365. DOI: 10.1007/s11060-017-2725-0. View

Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou A, Agnantis N . Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol. 2004; 130(7):405-10. DOI: 10.1007/s00432-004-0548-9. View

Kabat G, Etgen A, Rohan T . Do steroid hormones play a role in the etiology of glioma?. Cancer Epidemiol Biomarkers Prev. 2010; 19(10):2421-7. DOI: 10.1158/1055-9965.EPI-10-0658. View

10.

Barabas K, Szego E, Kaszas A, Nagy G, Juhasz G, Abraham I . Sex differences in oestrogen-induced p44/42 MAPK phosphorylation in the mouse brain in vivo. J Neuroendocrinol. 2006; 18(8):621-8. DOI: 10.1111/j.1365-2826.2006.01447.x. View

11.

Cowppli-Bony A, Bouvier G, Rue M, Loiseau H, Vital A, Lebailly P . Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control. 2011; 22(5):697-714. DOI: 10.1007/s10552-011-9742-7. View

12.

Carroll R, Zhang J, Dashner K, Sar M, Black P . Steroid hormone receptors in astrocytic neoplasms. Neurosurgery. 1995; 37(3):496-503; discussion 503-4. DOI: 10.1227/00006123-199509000-00019. View

13.

Anic G, Madden M, Nabors L, Olson J, LaRocca R, Thompson Z . Reproductive factors and risk of primary brain tumors in women. J Neurooncol. 2014; 118(2):297-304. PMC: 4048769. DOI: 10.1007/s11060-014-1427-0. View

14.

Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M . Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol. 2006; 164(7):629-36. DOI: 10.1093/aje/kwj254. View

15.

Liu C, Zhang Y, Zhang K, Bian C, Zhao Y, Zhang J . Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors. Cancer Epidemiol. 2014; 38(3):291-7. DOI: 10.1016/j.canep.2014.03.001. View

16.

Yuan Y, Liu L, Chen H, Wang Y, Xu Y, Mao H . Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients. Cancer Cell. 2016; 29(5):711-722. PMC: 4864951. DOI: 10.1016/j.ccell.2016.04.001. View

17.

Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M . Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110. PMC: 2818769. DOI: 10.1016/j.ccr.2009.12.020. View

18.

Pina-Medina A, Hansberg-Pastor V, Gonzalez-Arenas A, Cerbon M, Camacho-Arroyo I . Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells. Steroids. 2015; 105:19-25. DOI: 10.1016/j.steroids.2015.11.008. View

19.

Hernandez-Hernandez O, Gonzalez-Garcia T, Camacho-Arroyo I . Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines. J Steroid Biochem Mol Biol. 2012; 132(1-2):127-34. DOI: 10.1016/j.jsbmb.2012.04.005. View

20.

German-Castelan L, Manjarrez-Marmolejo J, Gonzalez-Arenas A, Camacho-Arroyo I . Intracellular Progesterone Receptor Mediates the Increase in Glioblastoma Growth Induced by Progesterone in the Rat Brain. Arch Med Res. 2016; 47(6):419-426. DOI: 10.1016/j.arcmed.2016.10.002. View